We have recently blogged about aspirin and all cancer risk reduction, but an interesting report at the recent American Society of Clinical Oncology meeting may provide more understanding http://abstract.asco.org/AbstView_114_99184.html.
A population based study of breast cancer patients in Ireland of various stages who were followed for a mean of 3.3 years was reported, specifically comparing two groups: aspirin users and nonusers.
The Irish have a General Medical Service with data on drug refills and a Linked National Cancer Registry that the researchers used in the study to document aspirin use. Those women who used aspirin (75mg/day) had a reduction in all cause mortality and breast cancer specific mortality when compared to nonusers. When they reviewed the data of high aspirin exposure (filled prescriptions for at least 83% of days) vs low use (58% of days) they found that only the high users saw the benefits: 30% fewer deaths and 37% fewer deaths related to breast cancer.
The take home message: those breast cancer survivors who take aspirin (81mg in the US) every day, not only have fewer recurrences (previous studies), but fewer deaths!
You need to discuss aspirin use with your doctor to make certain it is right for you.
Together we can prevent 75,000 breast cancer cases each year!
Remember this medical content is information and not personal medical advice.
No comments:
Post a Comment